Rank | Gene Set | Z-score |
---|---|---|
1 | progesterone metabolic process (GO:0042448) | 9.69750831 |
2 | cellular response to interferon-alpha (GO:0035457) | 9.52333933 |
3 | response to follicle-stimulating hormone (GO:0032354) | 9.25358617 |
4 | androgen metabolic process (GO:0008209) | 8.64216049 |
5 | * hormone biosynthetic process (GO:0042446) | 8.48412343 |
6 | cellular response to growth hormone stimulus (GO:0071378) | 8.42791174 |
7 | * ketone biosynthetic process (GO:0042181) | 7.66301639 |
8 | adhesion of symbiont to host (GO:0044406) | 7.62653494 |
9 | cellular response to epinephrine stimulus (GO:0071872) | 7.33862819 |
10 | cellular response to antibiotic (GO:0071236) | 7.22019548 |
11 | toxin metabolic process (GO:0009404) | 7.10767108 |
12 | estrogen metabolic process (GO:0008210) | 7.03993905 |
13 | response to lead ion (GO:0010288) | 6.60927397 |
14 | low-density lipoprotein particle clearance (GO:0034383) | 6.25556098 |
15 | response to epinephrine (GO:0071871) | 6.01152485 |
16 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.72736659 |
17 | phagocytosis, recognition (GO:0006910) | 5.45730060 |
18 | cellular response to gonadotropin stimulus (GO:0071371) | 5.42510347 |
19 | response to leptin (GO:0044321) | 5.35293852 |
20 | cellular response to toxic substance (GO:0097237) | 5.14007264 |
21 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.81428345 |
22 | mating behavior (GO:0007617) | 4.75074720 |
23 | regulation of male gonad development (GO:2000018) | 4.65078492 |
24 | cytokine metabolic process (GO:0042107) | 4.63489430 |
25 | benzene-containing compound metabolic process (GO:0042537) | 4.58987653 |
26 | cellular response to dexamethasone stimulus (GO:0071549) | 4.44390805 |
27 | response to growth hormone (GO:0060416) | 4.43823476 |
28 | intracellular lipid transport (GO:0032365) | 4.36088372 |
29 | positive regulation of male gonad development (GO:2000020) | 4.34811906 |
30 | sterol catabolic process (GO:0016127) | 4.31459323 |
31 | cholesterol catabolic process (GO:0006707) | 4.31459323 |
32 | response to corticosterone (GO:0051412) | 4.27641856 |
33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.24115250 |
34 | response to interferon-alpha (GO:0035455) | 4.21463297 |
35 | response to dexamethasone (GO:0071548) | 4.18896978 |
36 | NADP metabolic process (GO:0006739) | 4.06719648 |
37 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 4.06340956 |
38 | * steroid biosynthetic process (GO:0006694) | 4.02513043 |
39 | detection of molecule of bacterial origin (GO:0032490) | 3.90198449 |
40 | response to gonadotropin (GO:0034698) | 3.88170569 |
41 | cellular response to catecholamine stimulus (GO:0071870) | 3.80869279 |
42 | cellular response to monoamine stimulus (GO:0071868) | 3.80869279 |
43 | * cellular hormone metabolic process (GO:0034754) | 3.76977210 |
44 | catecholamine biosynthetic process (GO:0042423) | 3.75586176 |
45 | catechol-containing compound biosynthetic process (GO:0009713) | 3.75586176 |
46 | circadian sleep/wake cycle process (GO:0022410) | 3.69777460 |
47 | linoleic acid metabolic process (GO:0043651) | 3.64681669 |
48 | bile acid biosynthetic process (GO:0006699) | 3.63580239 |
49 | regulation of cholesterol storage (GO:0010885) | 3.63295720 |
50 | positive regulation of vascular permeability (GO:0043117) | 3.61390953 |
51 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.51997577 |
52 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.47525918 |
53 | response to mineralocorticoid (GO:0051385) | 3.45884677 |
54 | * cellular ketone metabolic process (GO:0042180) | 3.44424936 |
55 | regulation of female gonad development (GO:2000194) | 3.43748481 |
56 | response to cadmium ion (GO:0046686) | 3.41714970 |
57 | high-density lipoprotein particle remodeling (GO:0034375) | 3.37292164 |
58 | response to insecticide (GO:0017085) | 3.27874847 |
59 | response to monoamine (GO:0071867) | 3.22738546 |
60 | response to catecholamine (GO:0071869) | 3.22738546 |
61 | response to phenylpropanoid (GO:0080184) | 3.22709103 |
62 | sterol transport (GO:0015918) | 3.02114509 |
63 | cholesterol transport (GO:0030301) | 3.02114509 |
64 | reverse cholesterol transport (GO:0043691) | 2.92909336 |
65 | * sterol metabolic process (GO:0016125) | 2.89462182 |
66 | regulation of steroid biosynthetic process (GO:0050810) | 2.88000888 |
67 | circadian behavior (GO:0048512) | 2.86445212 |
68 | multicellular organismal aging (GO:0010259) | 2.75952206 |
69 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.74829180 |
70 | plasma lipoprotein particle clearance (GO:0034381) | 2.72019102 |
71 | secondary metabolic process (GO:0019748) | 2.68584777 |
72 | blood vessel endothelial cell migration (GO:0043534) | 2.65033606 |
73 | cholesterol metabolic process (GO:0008203) | 2.64438767 |
74 | Leydig cell differentiation (GO:0033327) | 2.62183849 |
75 | rhythmic behavior (GO:0007622) | 2.61349970 |
76 | response to vitamin E (GO:0033197) | 2.57829355 |
77 | * hormone metabolic process (GO:0042445) | 2.55632060 |
78 | vitamin D metabolic process (GO:0042359) | 2.52546684 |
79 | positive regulation of monooxygenase activity (GO:0032770) | 2.49606426 |
80 | * cellular response to metal ion (GO:0071248) | 2.48138276 |
81 | cochlea development (GO:0090102) | 2.47621302 |
82 | regulation of triglyceride metabolic process (GO:0090207) | 2.46610065 |
83 | cholesterol efflux (GO:0033344) | 2.44757094 |
84 | cellular response to ketone (GO:1901655) | 2.41713628 |
85 | positive regulation of lipid storage (GO:0010884) | 2.38312569 |
86 | catecholamine metabolic process (GO:0006584) | 2.35627503 |
87 | catechol-containing compound metabolic process (GO:0009712) | 2.35627503 |
88 | maintenance of protein location in nucleus (GO:0051457) | 2.34035741 |
89 | cellular response to cAMP (GO:0071320) | 2.31451495 |
90 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.25544751 |
91 | phenol-containing compound catabolic process (GO:0019336) | 2.24148895 |
92 | * C21-steroid hormone biosynthetic process (GO:0006700) | 18.8923584 |
93 | androgen biosynthetic process (GO:0006702) | 16.2170070 |
94 | estrogen biosynthetic process (GO:0006703) | 15.7593541 |
95 | cellular response to cadmium ion (GO:0071276) | 14.1138758 |
96 | * glucocorticoid biosynthetic process (GO:0006704) | 12.7838564 |
97 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 12.5295794 |
98 | * glucocorticoid metabolic process (GO:0008211) | 12.1508084 |
99 | * C21-steroid hormone metabolic process (GO:0008207) | 11.2511850 |
100 | cellular response to zinc ion (GO:0071294) | 10.6207484 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.13216366 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.11912684 |
3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.07798878 |
4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.33832197 |
5 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.33008735 |
6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.25322868 |
7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.14989198 |
8 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.08999416 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.05590080 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03592930 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39663158 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39663158 |
13 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.08362281 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03072972 |
15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.02125859 |
16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.01846761 |
17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01307332 |
18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.99633755 |
19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98902400 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97013788 |
21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94124429 |
22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.93741442 |
23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93004479 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89386288 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89125383 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88533789 |
27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83836830 |
28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82297785 |
29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82202487 |
30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75805305 |
31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.73599601 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73314117 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70980956 |
34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70321143 |
35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70086402 |
36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66732311 |
37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64627602 |
38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.64397576 |
39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61712830 |
40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.53268430 |
41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53125974 |
42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51826473 |
43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50024826 |
44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46040433 |
45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42464960 |
46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40807977 |
47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40589662 |
48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40589662 |
49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40338572 |
50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.37534176 |
51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36491779 |
52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32163165 |
53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30156573 |
54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28244565 |
55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22917425 |
56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21263566 |
57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19864405 |
58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17599182 |
59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17093603 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16908965 |
61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16642491 |
62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16432345 |
63 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12912325 |
64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12583642 |
65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09954379 |
66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06834871 |
67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05862961 |
68 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.05533392 |
69 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05493498 |
70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03994124 |
71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99719644 |
72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96833991 |
73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96431236 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96250431 |
75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96051373 |
76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94323835 |
77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94309913 |
78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91443461 |
79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91374082 |
80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90420185 |
81 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90379507 |
82 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89317776 |
83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.89194539 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87637476 |
85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85776567 |
86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84167686 |
87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83503030 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82246755 |
89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81655287 |
90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80789094 |
91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80319059 |
92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80319059 |
93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80271076 |
94 | P68_20966046_ChIP-Seq_HELA_Human | 0.78935013 |
95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76898309 |
96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76811516 |
97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.76352106 |
98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.76161353 |
99 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.75401598 |
100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74563326 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002909_abnormal_adrenal_gland | 9.49321910 |
2 | * MP0000639_abnormal_adrenal_gland | 8.04437395 |
3 | MP0002822_catalepsy | 4.72499705 |
4 | * MP0001765_abnormal_ion_homeostasis | 3.85794679 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.33076299 |
6 | MP0004084_abnormal_cardiac_muscle | 2.79873960 |
7 | * MP0000230_abnormal_systemic_arterial | 2.79683156 |
8 | MP0000631_abnormal_neuroendocrine_gland | 2.63496313 |
9 | * MP0005636_abnormal_mineral_homeostasis | 2.52110288 |
10 | MP0005647_abnormal_sex_gland | 2.42112359 |
11 | MP0004883_abnormal_blood_vessel | 2.39451334 |
12 | MP0004085_abnormal_heartbeat | 2.33553294 |
13 | MP0000566_synostosis | 2.32018119 |
14 | * MP0005319_abnormal_enzyme/_coenzyme | 2.13198623 |
15 | MP0003300_gastrointestinal_ulcer | 2.12393169 |
16 | MP0010329_abnormal_lipoprotein_level | 2.07848106 |
17 | MP0000538_abnormal_urinary_bladder | 1.88405527 |
18 | * MP0003953_abnormal_hormone_level | 1.65372539 |
19 | MP0006138_congestive_heart_failure | 1.62223516 |
20 | MP0004036_abnormal_muscle_relaxation | 1.59219113 |
21 | MP0003942_abnormal_urinary_system | 1.55287492 |
22 | MP0009053_abnormal_anal_canal | 1.44357105 |
23 | MP0008961_abnormal_basal_metabolism | 1.43799035 |
24 | MP0005164_abnormal_response_to | 1.36903382 |
25 | * MP0003638_abnormal_response/metabolism_ | 1.25516045 |
26 | MP0000537_abnormal_urethra_morphology | 1.22375701 |
27 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.21919986 |
28 | MP0008872_abnormal_physiological_respon | 1.20022350 |
29 | MP0003122_maternal_imprinting | 1.18262280 |
30 | MP0002118_abnormal_lipid_homeostasis | 1.16718495 |
31 | MP0001440_abnormal_grooming_behavior | 1.16563276 |
32 | MP0001879_abnormal_lymphatic_vessel | 1.11481461 |
33 | MP0001501_abnormal_sleep_pattern | 1.09466887 |
34 | MP0004145_abnormal_muscle_electrophysio | 1.09053730 |
35 | MP0003385_abnormal_body_wall | 1.08671442 |
36 | MP0002078_abnormal_glucose_homeostasis | 1.05593700 |
37 | MP0000343_altered_response_to | 1.05417412 |
38 | * MP0009643_abnormal_urine_homeostasis | 1.04775886 |
39 | MP0003283_abnormal_digestive_organ | 1.03946646 |
40 | MP0005452_abnormal_adipose_tissue | 1.03651465 |
41 | MP0000751_myopathy | 1.03112552 |
42 | MP0002160_abnormal_reproductive_system | 1.01032074 |
43 | MP0003123_paternal_imprinting | 1.00292246 |
44 | MP0005503_abnormal_tendon_morphology | 0.97808540 |
45 | MP0009250_abnormal_appendicular_skeleto | 0.97608685 |
46 | MP0005595_abnormal_vascular_smooth | 0.95757828 |
47 | MP0005535_abnormal_body_temperature | 0.92393301 |
48 | MP0003948_abnormal_gas_homeostasis | 0.90897424 |
49 | MP0002295_abnormal_pulmonary_circulatio | 0.90387924 |
50 | MP0000609_abnormal_liver_physiology | 0.87378028 |
51 | MP0005385_cardiovascular_system_phenoty | 0.86220338 |
52 | MP0001544_abnormal_cardiovascular_syste | 0.86220338 |
53 | MP0010368_abnormal_lymphatic_system | 0.84707337 |
54 | MP0001119_abnormal_female_reproductive | 0.80029660 |
55 | * MP0010630_abnormal_cardiac_muscle | 0.78634588 |
56 | MP0001529_abnormal_vocalization | 0.78100377 |
57 | MP0008874_decreased_physiological_sensi | 0.77600913 |
58 | MP0003724_increased_susceptibility_to | 0.76742736 |
59 | MP0001177_atelectasis | 0.75505950 |
60 | MP0004272_abnormal_basement_membrane | 0.75232757 |
61 | * MP0009642_abnormal_blood_homeostasis | 0.74906261 |
62 | * MP0000266_abnormal_heart_morphology | 0.70870428 |
63 | * MP0001756_abnormal_urination | 0.69527470 |
64 | * MP0002069_abnormal_eating/drinking_beha | 0.69181876 |
65 | MP0008438_abnormal_cutaneous_collagen | 0.69086719 |
66 | MP0003635_abnormal_synaptic_transmissio | 0.67165699 |
67 | MP0003115_abnormal_respiratory_system | 0.65832692 |
68 | MP0004130_abnormal_muscle_cell | 0.65684452 |
69 | MP0008775_abnormal_heart_ventricle | 0.64329140 |
70 | MP0004858_abnormal_nervous_system | 0.64026386 |
71 | MP0002249_abnormal_larynx_morphology | 0.63575493 |
72 | MP0002269_muscular_atrophy | 0.63239413 |
73 | MP0000003_abnormal_adipose_tissue | 0.62063607 |
74 | MP0003091_abnormal_cell_migration | 0.61374833 |
75 | MP0003705_abnormal_hypodermis_morpholog | 0.61049064 |
76 | MP0002127_abnormal_cardiovascular_syste | 0.60928416 |
77 | MP0002135_abnormal_kidney_morphology | 0.59945481 |
78 | MP0003191_abnormal_cellular_cholesterol | 0.59073677 |
79 | MP0005670_abnormal_white_adipose | 0.58400259 |
80 | MP0000249_abnormal_blood_vessel | 0.58339984 |
81 | MP0005365_abnormal_bile_salt | 0.58123094 |
82 | * MP0008469_abnormal_protein_level | 0.57159451 |
83 | MP0005389_reproductive_system_phenotype | 0.56993608 |
84 | MP0000778_abnormal_nervous_system | 0.56348117 |
85 | MP0005375_adipose_tissue_phenotype | 0.56211452 |
86 | MP0008770_decreased_survivor_rate | 0.56069880 |
87 | MP0001614_abnormal_blood_vessel | 0.54900971 |
88 | MP0002557_abnormal_social/conspecific_i | 0.53288893 |
89 | MP0001348_abnormal_lacrimal_gland | 0.51829039 |
90 | * MP0004087_abnormal_muscle_fiber | 0.51720464 |
91 | MP0003755_abnormal_palate_morphology | 0.51011692 |
92 | MP0003566_abnormal_cell_adhesion | 0.50152743 |
93 | MP0000653_abnormal_sex_gland | 0.49080756 |
94 | MP0000703_abnormal_thymus_morphology | 0.48896684 |
95 | * MP0010770_preweaning_lethality | 0.48614739 |
96 | * MP0002082_postnatal_lethality | 0.48614739 |
97 | MP0002139_abnormal_hepatobiliary_system | 0.48316794 |
98 | * MP0010769_abnormal_survival | 0.48006366 |
99 | MP0000013_abnormal_adipose_tissue | 0.47362390 |
100 | MP0000678_abnormal_parathyroid_gland | 0.47052495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoplasia of the uterus (HP:0000013) | 8.13804629 |
2 | Aplasia/hypoplasia of the uterus (HP:0008684) | 7.01977036 |
3 | Sex reversal (HP:0012245) | 6.70565774 |
4 | Abnormal sex determination (HP:0012244) | 6.70565774 |
5 | * Abnormality of renin-angiotensin system (HP:0000847) | 6.47035815 |
6 | Adrenal overactivity (HP:0002717) | 5.56789563 |
7 | Bifid scrotum (HP:0000048) | 5.50856879 |
8 | Accelerated skeletal maturation (HP:0005616) | 5.30613640 |
9 | Testicular neoplasm (HP:0010788) | 4.80536028 |
10 | * Neonatal onset (HP:0003623) | 4.69281365 |
11 | Azoospermia (HP:0000027) | 4.66382337 |
12 | Hypokalemia (HP:0002900) | 4.30741982 |
13 | Clitoromegaly (HP:0000057) | 4.22408981 |
14 | Neonatal hypoglycemia (HP:0001998) | 3.54674491 |
15 | Gonadal dysgenesis (HP:0000133) | 3.26912874 |
16 | Abnormality of secondary sexual hair (HP:0009888) | 3.19397550 |
17 | Abnormality of the axillary hair (HP:0100134) | 3.19397550 |
18 | * Abnormality of potassium homeostasis (HP:0011042) | 3.06878377 |
19 | Abnormal spermatogenesis (HP:0008669) | 3.06132240 |
20 | Precocious puberty (HP:0000826) | 2.96578587 |
21 | Male pseudohermaphroditism (HP:0000037) | 2.95660762 |
22 | Multifactorial inheritance (HP:0001426) | 2.94111827 |
23 | Abnormality of the clitoris (HP:0000056) | 2.92198933 |
24 | Septate vagina (HP:0001153) | 2.75908939 |
25 | Scrotal hypoplasia (HP:0000046) | 2.73238927 |
26 | Shawl scrotum (HP:0000049) | 2.68413063 |
27 | Hypothermia (HP:0002045) | 2.66399319 |
28 | Facial hemangioma (HP:0000329) | 2.64970107 |
29 | Breast hypoplasia (HP:0003187) | 2.47165351 |
30 | Prolonged QT interval (HP:0001657) | 2.44178828 |
31 | Hypospadias (HP:0000047) | 2.43465805 |
32 | Aplasia of the musculature (HP:0100854) | 2.41189755 |
33 | Sparse lateral eyebrow (HP:0005338) | 2.39478237 |
34 | Premature ovarian failure (HP:0008209) | 2.31467272 |
35 | Abnormal hemoglobin (HP:0011902) | 2.22491402 |
36 | Broad alveolar ridges (HP:0000187) | 2.21565336 |
37 | Bifid tongue (HP:0010297) | 2.19725055 |
38 | Breech presentation (HP:0001623) | 2.19381217 |
39 | Overlapping toe (HP:0001845) | 2.12507160 |
40 | Lymphangioma (HP:0100764) | 2.11330737 |
41 | Atrioventricular block (HP:0001678) | 2.07966466 |
42 | Abnormality of proline metabolism (HP:0010907) | 2.04028396 |
43 | Hydroxyprolinuria (HP:0003080) | 2.04028396 |
44 | Hyperglycinuria (HP:0003108) | 2.02188046 |
45 | Microglossia (HP:0000171) | 2.01291980 |
46 | * Orthostatic hypotension (HP:0001278) | 2.00950979 |
47 | Decreased circulating renin level (HP:0003351) | 13.0579362 |
48 | Enlarged penis (HP:0000040) | 11.4150042 |
49 | * Renal salt wasting (HP:0000127) | 10.3920179 |
50 | Hyperaldosteronism (HP:0000859) | 10.0785149 |
51 | Coronal craniosynostosis (HP:0004440) | 1.97133819 |
52 | Secondary amenorrhea (HP:0000869) | 1.96756167 |
53 | Increased nuchal translucency (HP:0010880) | 1.93169487 |
54 | Absent hand (HP:0004050) | 1.92531524 |
55 | Syncope (HP:0001279) | 1.89860328 |
56 | Broad metatarsal (HP:0001783) | 1.81081784 |
57 | Increased number of teeth (HP:0011069) | 1.80799155 |
58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77159560 |
59 | Abnormality of glycine metabolism (HP:0010895) | 1.77159560 |
60 | Pulmonary fibrosis (HP:0002206) | 1.74595146 |
61 | Hypoplastic nipples (HP:0002557) | 1.72190648 |
62 | Generalized hypotonia (HP:0001290) | 1.71698465 |
63 | Ureteral stenosis (HP:0000071) | 1.68847525 |
64 | Ketoacidosis (HP:0001993) | 1.68403294 |
65 | Hyperpituitarism (HP:0010514) | 1.62601633 |
66 | Gastrointestinal dysmotility (HP:0002579) | 1.60307532 |
67 | Bicornuate uterus (HP:0000813) | 1.56737579 |
68 | Bronchomalacia (HP:0002780) | 1.49816416 |
69 | Delayed CNS myelination (HP:0002188) | 1.48954241 |
70 | Complement deficiency (HP:0004431) | 1.48532828 |
71 | Split hand (HP:0001171) | 1.46439544 |
72 | Colitis (HP:0002583) | 1.44924414 |
73 | Capillary hemangiomas (HP:0005306) | 1.43127075 |
74 | Ureteral obstruction (HP:0006000) | 1.41476036 |
75 | Supranuclear gaze palsy (HP:0000605) | 1.41229061 |
76 | Advanced eruption of teeth (HP:0006288) | 1.38699448 |
77 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.37791800 |
78 | Poor suck (HP:0002033) | 1.37569828 |
79 | Turricephaly (HP:0000262) | 1.36568885 |
80 | Hemorrhage of the eye (HP:0011885) | 1.36311871 |
81 | Ketosis (HP:0001946) | 1.33655417 |
82 | Abnormal EKG (HP:0003115) | 1.32698847 |
83 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.32681033 |
84 | Hyperacusis (HP:0010780) | 1.32533199 |
85 | Cortical visual impairment (HP:0100704) | 1.31461854 |
86 | Decreased testicular size (HP:0008734) | 1.31353358 |
87 | Hammertoe (HP:0001765) | 1.31047105 |
88 | Heterotopia (HP:0002282) | 1.28517269 |
89 | Hypercalciuria (HP:0002150) | 1.27843157 |
90 | Pigmentary retinal degeneration (HP:0001146) | 1.27106028 |
91 | Heart block (HP:0012722) | 1.27098391 |
92 | Rectal prolapse (HP:0002035) | 1.26248667 |
93 | Ovarian neoplasm (HP:0100615) | 1.25637499 |
94 | Buphthalmos (HP:0000557) | 1.25200182 |
95 | Visceral angiomatosis (HP:0100761) | 1.24128585 |
96 | * Primary adrenal insufficiency (HP:0008207) | 1.23869395 |
97 | Overriding aorta (HP:0002623) | 1.22440669 |
98 | Complete atrioventricular canal defect (HP:0001674) | 1.21684047 |
99 | Oligomenorrhea (HP:0000876) | 1.20991909 |
100 | Abnormality of the alveolar ridges (HP:0006477) | 1.19690514 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.17892897 |
2 | TRIB3 | 4.05752764 |
3 | SIK1 | 4.00596104 |
4 | SIK3 | 2.95866216 |
5 | SIK2 | 2.75540472 |
6 | TAOK3 | 2.70992460 |
7 | CDK7 | 2.54744429 |
8 | EPHB2 | 2.05457381 |
9 | AKT3 | 10.3088737 |
10 | CAMK1G | 1.90763633 |
11 | BCKDK | 1.62159094 |
12 | PNCK | 1.57070341 |
13 | TIE1 | 1.54036782 |
14 | PKN2 | 1.53238285 |
15 | FGFR4 | 1.51754403 |
16 | FGFR2 | 1.42398572 |
17 | KDR | 1.27010363 |
18 | STK39 | 1.26853164 |
19 | PTK6 | 1.12347289 |
20 | RIPK1 | 1.11945206 |
21 | WNK4 | 1.06538635 |
22 | UHMK1 | 1.06455432 |
23 | CAMK1D | 1.05716794 |
24 | LRRK2 | 1.04973788 |
25 | BRD4 | 0.95756057 |
26 | ICK | 0.95144750 |
27 | TGFBR2 | 0.93151640 |
28 | MST1R | 0.91739618 |
29 | MARK2 | 0.84398919 |
30 | MET | 0.83729500 |
31 | PRKD1 | 0.83616358 |
32 | NTRK3 | 0.79955914 |
33 | NTRK1 | 0.79355026 |
34 | MAPK3 | 0.79213118 |
35 | FER | 0.75549438 |
36 | MAPKAPK5 | 0.75197504 |
37 | PAK4 | 0.73868577 |
38 | IRAK2 | 0.71039678 |
39 | PRKCH | 0.70340837 |
40 | LATS2 | 0.70046354 |
41 | RIPK4 | 0.66466985 |
42 | PAK6 | 0.66185847 |
43 | DYRK1B | 0.64871539 |
44 | ALK | 0.63576699 |
45 | KSR2 | 0.62402318 |
46 | PTK2 | 0.61366703 |
47 | DMPK | 0.59281678 |
48 | MAP3K1 | 0.49749109 |
49 | FGFR1 | 0.48931396 |
50 | TBK1 | 0.48702394 |
51 | EPHB1 | 0.48635627 |
52 | INSRR | 0.47076144 |
53 | MAPK12 | 0.46530244 |
54 | PHKG1 | 0.46102087 |
55 | PHKG2 | 0.46102087 |
56 | HIPK2 | 0.45016579 |
57 | PRKACB | 0.44827581 |
58 | IRAK3 | 0.44759369 |
59 | GSK3A | 0.44504309 |
60 | CAMK1 | 0.43490193 |
61 | CSNK1A1L | 0.43249360 |
62 | NTRK2 | 0.42587099 |
63 | PRKD2 | 0.42155477 |
64 | PDGFRA | 0.41981810 |
65 | PDPK1 | 0.40817076 |
66 | PRKACG | 0.40140007 |
67 | PRKACA | 0.40114491 |
68 | MAP3K7 | 0.39875037 |
69 | MARK3 | 0.39243775 |
70 | ILK | 0.39237320 |
71 | MAP2K1 | 0.39109923 |
72 | TGFBR1 | 0.37756795 |
73 | MARK1 | 0.37242769 |
74 | PRKCG | 0.36876768 |
75 | DYRK3 | 0.36333578 |
76 | MTOR | 0.34757831 |
77 | PAK3 | 0.33897458 |
78 | ERBB2 | 0.32782120 |
79 | MAP3K11 | 0.30725988 |
80 | CDK5 | 0.30569953 |
81 | CDC42BPA | 0.28260350 |
82 | MAPK1 | 0.27060186 |
83 | SRC | 0.27035706 |
84 | GRK6 | 0.26075108 |
85 | RPS6KA3 | 0.25049229 |
86 | PKN1 | 0.24834737 |
87 | MAP2K2 | 0.23766939 |
88 | CAMK4 | 0.23599614 |
89 | PRKD3 | 0.23255595 |
90 | CSNK1E | 0.22513117 |
91 | MINK1 | 0.22177377 |
92 | OXSR1 | 0.22020481 |
93 | RET | 0.21049808 |
94 | FES | 0.20387270 |
95 | MAPK9 | 0.20261249 |
96 | CAMKK1 | 0.20258949 |
97 | TNK2 | 0.18495072 |
98 | WNK1 | 0.18114518 |
99 | CAMK2B | 0.18057917 |
100 | IGF1R | 0.17887854 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 6.65916159 |
2 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 6.60818853 |
3 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 5.44480852 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.85998467 |
5 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.35538054 |
6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.22551260 |
7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.45677752 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30756784 |
9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.30622780 |
10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.27298316 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.03799418 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89931574 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86266798 |
14 | Bile secretion_Homo sapiens_hsa04976 | 1.75490075 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66113338 |
16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.61600477 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.61033623 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38457766 |
19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35058910 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.34435851 |
21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31554131 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16361982 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16003127 |
24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15086264 |
25 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02782200 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98993609 |
27 | Lysine degradation_Homo sapiens_hsa00310 | 0.97649131 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92502651 |
29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91802183 |
30 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88466490 |
31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77008649 |
32 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70473684 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69985817 |
34 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67886744 |
35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65176844 |
36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63912927 |
37 | Prostate cancer_Homo sapiens_hsa05215 | 0.63899611 |
38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59026226 |
39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56340810 |
40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55919576 |
41 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.54372212 |
42 | Insulin resistance_Homo sapiens_hsa04931 | 0.50494213 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45701254 |
44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43868482 |
45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43594835 |
46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.42338021 |
47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41903269 |
48 | Morphine addiction_Homo sapiens_hsa05032 | 0.41070932 |
49 | Peroxisome_Homo sapiens_hsa04146 | 0.37342322 |
50 | Prion diseases_Homo sapiens_hsa05020 | 0.36395467 |
51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35970782 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35270004 |
53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34854793 |
54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34471679 |
55 | Insulin secretion_Homo sapiens_hsa04911 | 0.33463692 |
56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31307127 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31084749 |
58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30140693 |
59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29997692 |
60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29835091 |
61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27839491 |
62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27661055 |
63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27226026 |
64 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.25672486 |
65 | Salivary secretion_Homo sapiens_hsa04970 | 0.25309736 |
66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23837256 |
67 | Axon guidance_Homo sapiens_hsa04360 | 0.23641059 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.23619301 |
69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.23264578 |
70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22670265 |
71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22270424 |
72 | Melanogenesis_Homo sapiens_hsa04916 | 0.22116076 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20264466 |
74 | Lysosome_Homo sapiens_hsa04142 | 0.19772644 |
75 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19314625 |
76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18899666 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18775311 |
78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17856569 |
79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17076823 |
80 | Focal adhesion_Homo sapiens_hsa04510 | 0.16958394 |
81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16682564 |
82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.16364191 |
83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.15709502 |
84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15268575 |
85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15115772 |
86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14490962 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13718374 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.13071907 |
89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.12683362 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12026425 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11717449 |
92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.11326765 |
93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.10957494 |
94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.10311796 |
95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08814979 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08365724 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.07696586 |
98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07681234 |
99 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.07114710 |
100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06559777 |